Catheter ablation for atrial fibrillation: a contemporary narrative review of indications, techniques, and emerging technologies

Q: What is the clinical evidence from this study?

Study design: Review. Population: Atrial fibrillation. Intervention: Catheter ablation vs. Drug therapy.

Q: What does this research mean for the field?

Catheter ablation, when performed in appropriately selected patients at optimal timing, is a highly effective treatment for atrial fibrillation that significantly improves symptoms and can positively affect prognosis. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Güney Sarıoğlu; Ertuğrul Kurtoğlu

doi:10.38053/acmj.1896183

May 22, 2026Anatolian Current Medical JournalOpen Access

Catheter ablation for atrial fibrillation: a contemporary narrative review of indications, techniques, and emerging technologies

View Full Paper

Ask AI

Bookmark

Share

Key result

Catheter ablation outperforms drug therapy in symptomatic AF, greatly improving symptoms and reducing AF burden.

Why the study?

Does catheter ablation improve outcomes compared to drug therapy in patients with atrial fibrillation?

Key Points

This review examines the indications and techniques for catheter ablation in atrial fibrillation, focusing on emerging technologies and their implications for treatment outcomes.
Narrative review summarizing existing literature on catheter ablation for atrial fibrillation.
Evaluation of technical principles, emerging technologies, and special considerations in patient care.
Discussion of effect measures including symptom relief, AF burden reduction, and survival improvements.
Rhythm control through catheter ablation is superior to drug therapy for symptomatic paroxysmal and persistent atrial fibrillation.
Pulmonary vein isolation and additional substrate ablation significantly improve patient outcomes in persistent AF.
New technologies like pulsed field ablation show promise in enhancing effectiveness and safety.

Structured PICO

Does catheter ablation improve outcomes compared to drug therapy in patients with atrial fibrillation?

P

Population

Patients with atrial fibrillation, including symptomatic paroxysmal and persistent AF, and those with concomitant structural heart disease and heart failure

I

Intervention

Catheter ablation (including pulmonary vein isolation, substrate ablation strategies, and pulsed field ablation)

C

Comparator

Drug therapy

O

Outcome

Rhythm control, reduction in AF burden, symptom improvement, and potential mortality/functional improvement

Catheter ablation is a key part of modern AF management that improves symptoms and can positively affect prognosis in appropriately selected patients.

Implication

Supports ablation for symptom relief in symptomatic AF; leaves open optimal selection and long-term outcomes with new technologies.

Abstract

This review summarises the current indications for catheter ablation in the treatment of atrial fibrillation (AF), its fundamental technical principles, and new technologies. The effects of rhythm control, which is superior to drug therapy in symptomatic paroxysmal and persistent AF, reduction in AF burden, and potential mortality/functional improvement are discussed; the fundamental role of pulmonary vein isolation, additional substrate ablation strategies in persistent AF, special considerations in patients with concomitant Structural heart disease (SHD) and heart failure, and new energies such as pulsed field ablation are evaluated. AF catheter ablation, performed in suitable patients, with optimal timing and in experienced centres, is a key part of modern AF management. It greatly improves symptoms and can positively affect prognosis in some groups. Advances in technology and personalised strategies are expected to improve effectiveness and reduce risks.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sarıoğlu et al. (2026) conducted a review in Atrial fibrillation. Catheter ablation vs. Drug therapy was evaluated. Catheter ablation for atrial fibrillation is superior to drug therapy in symptomatic paroxysmal and persistent AF, greatly improving symptoms and potentially reducing AF burden.

synapsesocial.com/papers/6a250ae37def13d035e1aefb https://doi.org/10.38053/acmj.1896183